Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision

Editing Process, automation, high-throughput screening, cloning workflow, process reproducibility, Scalability | July 24, 2025 | By Leah Chong, Ajay Panagariya
Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision
Share

Automating NGS library preparation to meet the scale of CRISPR research

Read the blog
CRISPR Confidence: The Power of Controls in Genome Editing
CRISPR Screening

CRISPR Confidence: The Power of Controls in Genome Editing

Key Takeaways CRISPR controls are essential for optimizing editing efficiency, validating phenotypes, and improving experimental reproducibility. Positive, negative, AAVS1, and lethal controls each serve distinct purposes throughout CRISPR workflows. CRISPR controls are widely used in functional genomics, pooled and arrayed screening, stem cell engineering, and drug discovery. EditCo provides validated CRISPR control reagents compatible with immortalized, primary, and iPSC models. Common CRISPR Control Types and Their Applications CRISPR genome editing is transforming biological research, and experimental controls are the backbone of reliable, reproducible results. In this article, we explore the essential role of CRISPR controls and supporting reagents in optimizing editing efficiency, troubleshooting workflows, and ensuring consistency across experiments. Whether you’re editing immortalized cells , iPSCs , or primary cells , CRISPR positive and negative controls are key to unlocking the full potential of your gene editing experiments. Why CRISPR Controls Matter CRISPR controls are not just “nice to have” — they are fundamental to every step of a genome editing experiment: Optimization: Use controls to fine-tune transfection parameters and editing protocols across different cell types and workflows. Controls help establish optimal conditions before investing in gene-specific reagents. Assay Development : Optimize transfection conditions and editing performance before targeting your gene of interest. Screening and Validation : Confirm editing efficiency and distinguish true biological effects from technical artifacts. Troubleshooting : Identify potential problems with delivery, reagent performance, or cell health. Without appropriate controls, even the most promising CRISPR screen can yield ambiguous or misleading results.

Read More
Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells
Editing Process

Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells

Key Takeaways • CRISPR editing can impair CD8+ T-cell function if editing and recovery conditions are not optimized. • EditCo’s workflow preserves cytotoxic activity after editing. • Edited T cells demonstrated up to 99% killing of CD19+ target cells in a BiTE assay. • Functional validation is just as important as editing efficiency. CRISPR-Cas9 is revolutionizing cell engineering, opening up new research possibilities such as easier disease modeling, clearer functional gene pathway analysis, novel drug target screening, or creating tailored immune cell therapies. However, not all cell lines are easily edited and often cell lines, such as primary immune cells, risk having their downstream functionality affected by the genetic changes or the editing process itself. One major hurdle researchers face when working with CD8+ T cells (also known as Cytotoxic T Cells or CTL) is maintaining their cytotoxicity after editing. The EditCo Bio R&D team recognized this challenge when developing our T cell editing process and was determined to succeed where others often falter.

Read More
Advancements in Karyotyping & the Impact on Cell-based Research
Disease Models

Advancements in Karyotyping & the Impact on Cell-based Research

Disease modeling using human pluripotent stem cells (hPSCs) has been crucial in drug discovery, and clinical applications. However, a challenge with working with hPSCs is that over time, as they're cultured in vitro, they can develop recurrent genomic abnormalities and copy number variations (CNVs) that may compromise research outcomes and therapeutic potentials. Some CNVs, such as the common 20q11.21 amplification, can confer selective advantages to cells but reduce their differentiation capacities. Therefore, monitoring and verifying the genomic integrity of hPSC cultures is an essential quality control measure in cell-based research.

Read More